On September 3, 2024 Indaptus Therapeutics, Inc. (Nasdaq: INDP) reported that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 26 th Annual Global Investment Conference. The conference is being held on September 9 – 11, 2024 at the Lotte New York Palace Hotel (Press release, Indaptus Therapeutics, SEP 3, 2024, View Source;qmodStoryID=5871576807142026 [SID1234646315]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Date: September 9, 2024
Time: Available on-demand starting at 7:00 AM Eastern Time
Webcast Link: View Source
A live webcast of the presentation can be accessed on the investor relations section of the Indaptus website. A replay of the webcast will be archived and available following the event for approximately 90 days.
View Source
Mr. Meckler will be available for one-on-one meetings throughout the conference. To request a meeting and to register for the conference, click below: